Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | KIF11 | P52732 | 3/20 | 0.54 |
| ▸ | ACHE | P22303 | 4/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 2/20 | 0.47 |
| ▸ | RXRB | P28702 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29289408 | 0.97 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| Methoxymethane SCHEMBL28022475 | 0.91 | HDAC8 (0.50) | HDAC8HDAC4HDAC2KIF11ACHE | |
| Nitrogen SCHEMBL28547462 | 0.91 | HDAC8 (0.50) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL28328740 | 0.89 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL7203019 | 0.89 | KIF11 (0.52) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL26621934 | 0.89 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL9492395 | 0.89 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL28653353 | 0.89 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL29002849 | 0.89 | HDAC8 (0.54) | HDAC8HDAC4HDAC2KIF11ACHE | |
| SCHEMBL25451230 | 0.87 | ACHE (0.52) | HDAC8HDAC4HDAC2KIF11ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059975-A | Eight-membered ring condensed boron dipyrrole compound and preparation method thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-19 | — | — | CN | claimed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | claimed |
| EP-4696679-A1 | CHIRAL PYRIDINIUM SALT CARBONYL CATALYST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Normal University (CN) | 2026-02-18 | — | — | EP | claimed |
| US-20250268292-A1 | PRODUCTION OF PHOSPHOLIPIDS IN MICROBES AND USES THEREOF | Nourish Ingredients Pty Ltd (AU) | 2025-08-28 | — | — | US | claimed |
| EP-4583720-A1 | COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | claimed |
| EP-4583719-A1 | COMPOSITIONS AND METHODS FOR PRODUCING AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | claimed |
| EP-4583721-A1 | COMPOSITIONS AND METHODS FOR PRODUCING MEAT-LIKE AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | claimed |
| EP-4583722-A1 | COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH MEAT-LIKE AROMAS | Nourish Ingredients Pty Ltd (AU) | 2025-07-16 | — | — | EP | claimed |
| CN-119936267-A | Method for detecting volatile organic compounds on human body surface by combining SPME-Arrow with GC-MS/MS | 公安部鉴定中心 | 2025-05-06 | — | — | CN | claimed |
| WO-2025002445-A1 | CHIRAL PYRIDINIUM SALT CARBONYL CATALYST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海师范大学 | 2025-01-02 | — | — | WO | claimed |
| EP-1910306-A1 | CARBON-NITROGEN BOND FORMING PROCESS | Shasun Pharma Solutions Limited (GB) | 2008-04-16 | — | — | EP | claimed |
| WO-2008036932-A2 | COMPOSITIONS AND METHODS COMPRISING BOSWELLIA SPECIES | HERBALSCIENCE SINGAPORE PTE. LTD. (US) | 2008-03-27 | — | — | WO | claimed |
| US-20070082271-A1 | Non-aqueous electrolytic solution and lithium secondary battery | UBE INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | claimed |
| WO-2007017734-A1 | CARBON-NITROGEN BOND FORMING PROCESS | SHASUN PHARMA SOLUTIONS LIMITED (GB) | 2007-02-15 | — | — | WO | claimed |
| EP-1691441-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2006-08-16 | — | — | EP | claimed |
| US-20060177742-A1 | Nonaqueous electrolytic solution for lithium secondary battery and lithium secondary battery using the same | MU IONIC SOLUTIONS CORPORATION (JP) | 2006-08-10 | — | — | US | claimed |
| EP-1650826-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2006-04-26 | — | — | EP | claimed |
| US-6503662-B1 | Tert-butylbenzene derivative prevents oxidation and decomposition of solvent at the time of charging which causes decreased battery characteristics | UBE INDUSTRIES, LTD. (JP) | 2003-01-07 | — | — | US | claimed |
| EP-0057882-B1 | 3,5-DI-TERT-BUTYLSTYRENE DERIVATIVES, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1986-04-02 | — | — | EP | claimed |
| US-4408083-A | SOLVENT EXTRACTION, THERMAL DECOMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | BCL2, BAX, EPCAM | HDAC8 3730/4885HDAC4 2565/4885HDAC2 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.